Dr. Rachel Saunders-Pullman, MD

Medical School - Columbia University, Doctor of Medicine

NewYork-Presbyterian Hospital, Internship in Internal Medicine

Columbia University Medical Center, Residency in Neurology

Columbia University Medical Center, Fellowship in Movement Disorders

Columbia University Medical Center, Fellowship in Epidemiology

American Board of Psychiatry and Neurology

Neurology (Psychiatry and Neurology)

Castle Connolly Top Doctor

Deik A, Saunders-Pullman R. Atypical presentation of late-onset Tay-Sachs disease. Muscle & nerve 2014 May; 49(5).

Swan M, Saunders-Pullman R. The association between ß-glucocerebrosidase mutations and parkinsonism. Current neurology and neuroscience reports 2013 Aug; 13(8).

Gan-Or Z, Ozelius LJ, Bar-Shira A, Saunders-Pullman R, Mirelman A, Kornreich R, Gana-Weisz M, Raymond D, Rozenkrantz L, Deik A, Gurevich T, Gross SJ, Schreiber-Agus N, Giladi N, Bressman SB, Orr-Urtreger A. The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease. Neurology 2013 Apr; 80(17).

Fuchs T, Saunders-Pullman R, Masuho I, Luciano MS, Raymond D, Factor S, Lang AE, Liang TW, Trosch RM, White S, Ainehsazan E, Hervé D, Sharma N, Ehrlich ME, Martemyanov KA, Bressman SB, Ozelius LJ. Mutations in GNAL cause primary torsion dystonia. Nature genetics 2013 Jan; 45(1).

López-Laso E, Beyer K, Opladen T, Artuch R, Saunders-Pullman R. Dyskinesias as a limiting factor in the treatment of Segawa disease. Pediatric neurology 2012 Jun; 46(6).

Female

#1720061757